A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain.

Trial Profile

A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Dexmedetomidine (Primary) ; Remifentanil (Primary)
  • Indications Postoperative pain
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms RemivsDex
  • Most Recent Events

    • 03 Jun 2016 Status changed from recruiting to completed.
    • 11 Feb 2013 Planned End Date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
    • 19 Feb 2011 Additional trial investigators identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top